Impact of Phospholipid Transfer Protein in Lipid Metabolism and Cardiovascular Diseases

Area of Science:

• Biochemistry and Molecular Biology
• Cardiovascular Research
• Lipid Metabolism

Background:

• Phospholipid transfer protein (PLTP) is implicated in lipoprotein metabolism and cardiovascular disease (CVD) pathogenesis in humans.
• Existing mouse models show conflicting results: PLTP deficiency reduces CVD, while overexpression exacerbates it, indicating complex regulatory roles.
• The precise mechanisms underlying PLTP's influence on CVD and lipid profiles remain incompletely elucidated.

Purpose of the Study:

• To investigate the mechanisms by which PLTP influences lipoprotein metabolism and cardiovascular disease progression.
• To summarize recent advancements in PLTP research, focusing on its role in lipid metabolism and CVD.
• To utilize mouse models to dissect the functional impact of PLTP in a controlled in vivo setting.

Main Methods:

• Utilized established mouse models with varying PLTP expression levels (deficiency and overexpression).
• Analyzed lipoprotein metabolism parameters in response to altered PLTP activity.
• Assessed cardiovascular disease development and progression in the context of PLTP modulation.

Main Results:

• PLTP deficiency was associated with reduced cardiovascular disease burden in mouse models.
• Overexpression of PLTP correlated with an increased incidence and severity of cardiovascular disease.
• Specific alterations in lipoprotein profiles were observed, linked to PLTP activity levels.

Conclusions:

• PLTP plays a critical, albeit complex, role in modulating cardiovascular disease risk through its effects on lipoprotein metabolism.
• Mouse models provide valuable insights into the in vivo mechanisms of PLTP action in cardiovascular health.
• Further research is warranted to fully understand PLTP's therapeutic potential in managing dyslipidemia and preventing cardiovascular events.